212 related articles for article (PubMed ID: 30165787)
1. Histone variant macroH2A1 rewires carbohydrate and lipid metabolism of hepatocellular carcinoma cells towards cancer stem cells.
Lo Re O; Douet J; Buschbeck M; Fusilli C; Pazienza V; Panebianco C; Castracani CC; Mazza T; Li Volti G; Vinciguerra M
Epigenetics; 2018; 13(8):829-845. PubMed ID: 30165787
[TBL] [Abstract][Full Text] [Related]
2. Induction of cancer cell stemness by depletion of macrohistone H2A1 in hepatocellular carcinoma.
Lo Re O; Fusilli C; Rappa F; Van Haele M; Douet J; Pindjakova J; Rocha SW; Pata I; Valčíková B; Uldrijan S; Yeung RS; Peixoto CA; Roskams T; Buschbeck M; Mazza T; Vinciguerra M
Hepatology; 2018 Feb; 67(2):636-650. PubMed ID: 28913935
[TBL] [Abstract][Full Text] [Related]
3. A Lipidomic Signature Complements Stemness Features Acquisition in Liver Cancer Cells.
Rivas Serna IM; Romito I; Maugeri A; Lo Re O; Giallongo S; Mazzoccoli G; Oben JA; Li Volti G; Mazza T; Alisi A; Vinciguerra M
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182805
[TBL] [Abstract][Full Text] [Related]
4. Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4
Lo Re O; Mazza T; Giallongo S; Sanna P; Rappa F; Vinh Luong T; Li Volti G; Drovakova A; Roskams T; Van Haele M; Tsochatzis E; Vinciguerra M
Theranostics; 2020; 10(2):910-924. PubMed ID: 31903159
[No Abstract] [Full Text] [Related]
5. Dysregulated lipid metabolism in hepatocellular carcinoma cancer stem cells.
Bort A; Sánchez BG; de Miguel I; Mateos-Gómez PA; Diaz-Laviada I
Mol Biol Rep; 2020 Apr; 47(4):2635-2647. PubMed ID: 32125560
[TBL] [Abstract][Full Text] [Related]
6. BORIS up-regulates OCT4 via histone methylation to promote cancer stem cell-like properties in human liver cancer cells.
Liu Q; Chen K; Liu Z; Huang Y; Zhao R; Wei L; Yu X; He J; Liu J; Qi J; Qin Y; Li B
Cancer Lett; 2017 Sep; 403():165-174. PubMed ID: 28645561
[TBL] [Abstract][Full Text] [Related]
7. DNA Hypomethylation and Histone Variant macroH2A1 Synergistically Attenuate Chemotherapy-Induced Senescence to Promote Hepatocellular Carcinoma Progression.
Borghesan M; Fusilli C; Rappa F; Panebianco C; Rizzo G; Oben JA; Mazzoccoli G; Faulkes C; Pata I; Agodi A; Rezaee F; Minogue S; Warren A; Peterson A; Sedivy JM; Douet J; Buschbeck M; Cappello F; Mazza T; Pazienza V; Vinciguerra M
Cancer Res; 2016 Feb; 76(3):594-606. PubMed ID: 26772755
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial Fuel Dependence on Glutamine Drives Chemo-Resistance in the Cancer Stem Cells of Hepatocellular Carcinoma.
Lee ACK; Lau PM; Kwan YW; Kong SK
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805044
[TBL] [Abstract][Full Text] [Related]
9. Active glycolytic metabolism in CD133(+) hepatocellular cancer stem cells: regulation by MIR-122.
Song K; Kwon H; Han C; Zhang J; Dash S; Lim K; Wu T
Oncotarget; 2015 Dec; 6(38):40822-35. PubMed ID: 26506419
[TBL] [Abstract][Full Text] [Related]
10. MiR-491 attenuates cancer stem cells-like properties of hepatocellular carcinoma by inhibition of GIT-1/NF-κB-mediated EMT.
Yang X; Ye J; Yan H; Tang Z; Shen J; Zhang J; Yang L
Tumour Biol; 2016 Jan; 37(1):201-9. PubMed ID: 26188902
[TBL] [Abstract][Full Text] [Related]
11. SRY and OCT4 Are Required for the Acquisition of Cancer Stem Cell-Like Properties and Are Potential Differentiation Therapy Targets.
Murakami S; Ninomiya W; Sakamoto E; Shibata T; Akiyama H; Tashiro F
Stem Cells; 2015 Sep; 33(9):2652-63. PubMed ID: 26013162
[TBL] [Abstract][Full Text] [Related]
12. lncARSR promotes liver cancer stem cells expansion via STAT3 pathway.
Yang C; Cai WC; Dong ZT; Guo JW; Zhao YJ; Sui CJ; Yang JM
Gene; 2019 Mar; 687():73-81. PubMed ID: 30391438
[TBL] [Abstract][Full Text] [Related]
13. SIRT1-mediated transcriptional regulation of SOX2 is important for self-renewal of liver cancer stem cells.
Liu L; Liu C; Zhang Q; Shen J; Zhang H; Shan J; Duan G; Guo D; Chen X; Cheng J; Xu Y; Yang Z; Yao C; Lai M; Qian C
Hepatology; 2016 Sep; 64(3):814-27. PubMed ID: 27312708
[TBL] [Abstract][Full Text] [Related]
14. Activation of Tyrosine Metabolism in CD13+ Cancer Stem Cells Drives Relapse in Hepatocellular Carcinoma.
Sun L; Zhang L; Chen J; Li C; Sun H; Wang J; Xiao H
Cancer Res Treat; 2020 Apr; 52(2):604-621. PubMed ID: 32019286
[TBL] [Abstract][Full Text] [Related]
15. Enrichment of cancer stem cells via β-catenin contributing to the tumorigenesis of hepatocellular carcinoma.
Pandit H; Li Y; Li X; Zhang W; Li S; Martin RCG
BMC Cancer; 2018 Aug; 18(1):783. PubMed ID: 30075764
[TBL] [Abstract][Full Text] [Related]
16. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
Huang WC; Tung SL; Chen YL; Chen PM; Chu PY
BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298
[TBL] [Abstract][Full Text] [Related]
17. A Novel Small-molecule WNT Inhibitor, IC-2, Has the Potential to Suppress Liver Cancer Stem Cells.
Seto K; Sakabe T; Itaba N; Azumi J; Oka H; Morimoto M; Umekita Y; Shiota G
Anticancer Res; 2017 Jul; 37(7):3569-3579. PubMed ID: 28668848
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA THOR promotes liver cancer stem cells expansion via β-catenin pathway.
Cheng Z; Lei Z; Yang P; Si A; Xiang D; Zhou J; Hüser N
Gene; 2019 Feb; 684():95-103. PubMed ID: 30359743
[TBL] [Abstract][Full Text] [Related]
19. Effects of low-density lipoprotein docosahexaenoic acid nanoparticles on cancer stem cells isolated from human hepatoma cell lines.
Yang J; Gong Y; Sontag DP; Corbin I; Minuk GY
Mol Biol Rep; 2018 Oct; 45(5):1023-1036. PubMed ID: 30069818
[TBL] [Abstract][Full Text] [Related]
20. Musashi 2 contributes to the stemness and chemoresistance of liver cancer stem cells via LIN28A activation.
Fang T; Lv H; Wu F; Wang C; Li T; Lv G; Tang L; Guo L; Tang S; Cao D; Wu M; Yang W; Wang H
Cancer Lett; 2017 Jan; 384():50-59. PubMed ID: 27721018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]